Reduction in the use of potentially inappropriate drugs among old people living in geriatric care units between 2007 and 2013

European Journal of Clinical Pharmacology

Volumn 71, Issue 4, 2015, Pages 507-515

  Gustafsson, Maria ^a,b   Sandman, Per Olof ^c   Karlsson, Stig ^a   Isaksson, Ulf ^a   Schneede, Jörn ^a   Sjölander, Maria ^a   Lövheim, Hugo ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Clinical pharmacist; Dementia; Medication reviews; Nursing home; Potentially inappropriate drug use

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; FLUNITRAZEPAM; HALOPERIDOL; HYDROXYZINE; LEVOMEPROMAZINE; LONG ACTING DRUG; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROPIOMAZINE; RISPERIDONE; TRAMADOL; PRESCRIPTION DRUG;

AGE DISTRIBUTION; AGED; ARTICLE; ASSESSMENT OF HUMANS; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DRUG USE; FEMALE; GERIATRIC CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTI DIMENSIONAL DEMENTIA ASSESSMENT SCALE; PARALLEL DESIGN; PHARMACIST; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SWEDEN; VERY ELDERLY; DEMENTIA; DRUG EFFECTS; DRUG UTILIZATION; HOME FOR THE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; POTENTIALLY INAPPROPRIATE MEDICATION; STATISTICS AND NUMERICAL DATA; TRENDS;

ACTIVITIES OF DAILY LIVING; AGED, 80 AND OVER; COGNITION; DEMENTIA; DRUG UTILIZATION; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; POTENTIALLY INAPPROPRIATE MEDICATION LIST; PRESCRIPTION DRUGS; PREVALENCE; SWEDEN;

EID: 84925465339     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-015-1825-z     Document Type: Article

References (40)

1. The National Board of Health and Welfare (2010) Indikatorer för utvärdering av kvaliteten i äldres läkemedelsterapi. [Eng. Indicators for evaluating the quality of older people's drug therapy]. http://www.socialstyrelsen.se/publikationer2010/2010-6-29/. Accessed 17 Nov 2014
2. Lau DT, Kasper JD, Potter DEB, Lyles A, Bennett RG (2005) Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 165(1):68-74
3. Lund BC, Carnahan RM, Egge JA, Chrischilles EA, Kaboli PJ (2010) Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 44(6):957-963
4. Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, Ruby CM, Schmader KE (2003) Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 1(2):82-89
5. Cancelli I, Beltrame M, Gigli GL, Valente M (2009) Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients. Neurol Sci 30(2):87-92
6. Gill SS, Bronskill SE, Normand S-LT, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA (2007) Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 146(11):775-786
7. Melkersson KI, Dahl M-L, Hulting A-L (2004) Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism. Psychopharmacology (Berlin) 175(1):1-6
8. Neil W, Curran S, Wattis J (2003) Antipsychotic prescribing in older people. Age Ageing 32(5):475-483
9. Schneider LS, Dagerman KS, Insel P (2005) Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294(15):1934-1943
10. Ray WA (1992) Psychotropic drugs and injuries among the elderly: a review. J Clin Psychopharmacol 12(6):386-396
11. Cumming RG, Le Couteur DG (2003) Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 17(11):825-837
12. Madhusoodanan S, Bogunovic OJ (2004) Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf 3(5):485-493
13. Haasum Y, Fastbom J, Johnell K (2012) Institutionalization as a risk factor for inappropriate drug use in the elderly: a Swedish nationwide register-based study. Ann Pharmacother 46(3):339-346
14. Gustafsson M, Karlsson S, Gustafson Y, Lövheim H (2013) Psychotropic drug use among people with dementia - a six-month follow-up study. BMC Pharmacol Toxicol 14(1):56
15. Hovstadius B, Petersson G, Hellström L, Ericson L (2014) Trends in inappropriate drug therapy prescription in the elderly in Sweden from 2006 to 2013: assessment using national indicators. Drugs Aging 31(5):379-386
16. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370(9582):173-184
17. Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ (1994) A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 47(8):891-896
18. American Geriatrics Society Beers Criteria Update Expert Panel (2012) American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60(4):616-631
19. Perri M 3rd, Menon AM, Deshpande AD, Shinde SB, Jiang R, Cooper JW, Cook CL, Griffin SC, Lorys RA (2005) Adverse outcomes associated with inappropriate drug use in nursing homes. Ann Pharmacother 39(3):405-411
20. Chang C-M, Liu P-YY, Yang Y-HK, Yang Y-C, Wu C-F, Lu F-H (2005) Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients. Pharmacotherapy 25(6):831-838
21. Spinewine A, Fialová D, Byrne S (2012) The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging 29(6):495-510
22. Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, Kettis-Lindblad A, Melhus H, Mörlin C (2009) A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med 169(9):894-900
23. Scullin C, Scott MG, Hogg A, McElnay JC (2007) An innovative approach to integrated medicines management. J Eval Clin Pract 13(5):781-788
24. Hellström LM, Bondesson A, Höglund P, Midlöv P, Holmdahl L, Rickhag E, Eriksson T (2011) Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol 67(7):741-752
25. Sandman PO, Adolfsson R, Norberg A, Nyström L, Winblad B (1988) Long-term care of the elderly. A descriptive study of 3600 institutionalized patients in the county of Västerbotten, Sweden. Compr Gerontol A 2(3):120-132
26. Adolfsson R, Gottfries CG, Nyström L, Winblad B (1981) Prevalence of dementia disorders in institutionalized Swedish old people. The work load imposed by caring for these patients. Acta Psychiatr Scand 63(3):225-244
27. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189-198
28. Hedström M, Lidström B, Åsberg K (2009) PHASE-20: ett nytt instrument för skattning av möjliga läkemedelsrelaterade symtom hos äldre personer i äldreboende. [Eng. A new instrument for assessment of possible drug-related symptoms in older people in geriatric care]. http://www.lul.se/Global/Extran%C3%A4t/V%C3%A5rdgivare/L%C3%A4kemedelsenheten/Dokument/Phase-20/PHASE-20ViN-Artikel.pdf/. Accessed 17 Nov 2014
29. Milos V, Rekman E, Bondesson Å, Eriksson T, Jakobsson U, Westerlund T, Midlöv P (2013) Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study. Drugs Aging 30(4):235-246
30. Bergman A, Olsson J, Carlsten A, Waern M, Fastbom J (2007) Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care 25(1):9-14
31. Medical products agency (2008) Läkemedelsverkets behandlingsrekommendationer: Läkemedelsbehandling och bemötande vid Beteendemässiga och Psykiska Symtom vid Demenssjukdom - BPSD. [Eng. Drug therapy and treatment for Behavioral and Psychological Symptoms of Dementia - BPSD]. http://www.lakemedelsverket.se/malgrupp/Halso - -sjukvard/Behandlings - rekommendationer/Behandlingsrekommendation - -listan/Beteendemassiga-och-psykiska-symtom-vid-demenssjukdom - BPSD/. Accessed 17 Nov 2014
32. Passarelli MCG, Jacob-Filho W, Figueras A (2005) Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 22(9):767-777
33. Klarin I, Wimo A, Fastbom J (2005) The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 22(1):69-82
34. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 79(15):1200-1205
35. Beijer HJM, de Blaey CJ (2002) Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 24(2):46-54
36. Mjörndal T, Boman MD, Hägg S, Bäckström M, Wiholm B-E, Wahlin A, Dahlqvist R (2002) Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf 11(1):65-72
37. Alldred DP, Raynor DK, Hughes C, Barber N, Chen TF, Spoor P (2013) Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev 2, CD009095
38. Wallerstedt SM, Kindblom JM, Nylén K, Samuelsson O, Strandell A (2014) Medication reviews for nursing home residents to reduce mortality and hospitalisation: systematic review and meta-analysis. Br J Clin Pharmacol 78(3):488-497
39. Tan ECK, Stewart K, Elliott RA, George J (2013) Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm 10(4):608-622
40. Graabaek T, Kjeldsen LJ (2013) Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol 112(6):359-373